Company intelligence / Profile preview

SkylineDx

Rotterdam, South Holland, Netherlandsskylinedx.com ↗

Ownership: Private
Development stage: Commercial

Overview

SkylineDx has developed and commercialized several molecular diagnostic tests that are CE-IVD marked in Europe. The Merlin™ Assay for melanoma nodal metastasis risk is commercially available in partnership with Biocartis. The MMProfiler assay for multiple myeloma has also received CE-IVD marking. Ongoing clinical collaborations aim to validate new biomarker-driven tests across oncology and inflammatory diseases.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Diagnostic assayMolecular diagnostic test
Industry: Molecular Diagnostics

Drug pipeline

2 assets

Merlin test

Commercial

Indications: Melanoma

1 more asset in the full pipeline.

Partnerships

Biocartis (co-development/commercialization of Merlin™ Assay for melanoma metastasis risk reduction in Europe)NeraCare (co-development/licensing agreement on Immunoprint proteomic test for high-risk early-stage melanoma patients)Flanders Institute of Biotechnology/VIB (“molecular diagnostics partnership” focused on unmet needs globally using single-cell technology to map tumor microenvironments and validate immunotherapy response biomarkers)

Beyond the preview

Go deeper on SkylineDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SkylineDx.